Role of distinct type IV collagen networks in glomerular development and function

被引:82
作者
Harvey, SJ
Zheng, KQ
Sado, Y
Naito, I
Ninomiya, Y
Jacobs, RM
Hudson, BG
Thorner, PS
机构
[1] Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Shigei Med Res Inst, Div Immunol, Okayama, Japan
[4] Shigei Med Res Inst, Div Ultrastruct Biol, Okayama, Japan
[5] Okayama Univ, Sch Med, Dept Biochem & Mol Biol, Okayama 700, Japan
[6] Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada
[7] Univ Guelph, Guelph, ON N1G 2W1, Canada
[8] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
关键词
Alport syndrome; hereditary nephritis; collagen type TV; collagen network; developmental switch;
D O I
10.1046/j.1523-1755.1998.00188.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. In X-linked Alport syndrome, mutations in the COL4A5 gene encoding the alpha 5 chain of type IV collagen result in progressive renal failure. This nephropathy appears to relate to the arrest of a switch from an alpha 1/alpha 2 to an alpha 3/alpha 4/alpha 5 network of type IV collagen in the developing glomerular basement membrane (GBM; Kalluri ct al, J Clin Invest 99:2470, 1997). Methods. We examined the role of this switch in glomerular development and function using a canine model of X-linked nephritis with a COL4A5 mutation. The electron microscopic appearance and the expression of the alpha 1-alpha 6 chains of type IV collagen in the GEM was correlated with glomerular function. Results. In normal neonatal glomeruli, once capillary loops were present, there was staining of GEM for the alpha 1-alpha 5 chains. Prior to this stage, only alpha 1 and alpha 2 chains were present, with rare glomeruli positive for the alpha 5 chain. As glomeruli matured, the alpha 1 and alpha 2 chains tended to disappear from the GEM, with the alpha 3-alpha 5 chains remaining. In affected male dogs, only the alpha 1 and alpha 2 chains were detected at any stage. GEM ultrastructure in these dogs remained normal until one month and proteinuria did not appear until two months. Conclusion. Our results show that normal glomerular development involves a switch in type IV collagen networks. In affected male dogs, a failure of this switch results in an absence of the alpha 3/alpha 4/alpha 5 network and a persistence of the alpha 1/alpha 2 network in GEM. GEM ultrastructure and glomerular function remain normal for one month, indicating that GEM deterioration in Alport syndrome begins as a postnatal process. Hence, only the alpha 1/alpha 2 network is essential for normal glomerular development, whereas the alpha 3/alpha 4/alpha 5 network is essential for long-term maintenance of glomerular structure and function.
引用
收藏
页码:1857 / 1866
页数:10
相关论文
共 32 条
[1]   ONTOGENY OF GLOMERULAR-BASEMENT-MEMBRANE - STRUCTURAL AND FUNCTIONAL-PROPERTIES [J].
DESJARDINS, M ;
BENDAYAN, M .
JOURNAL OF CELL BIOLOGY, 1991, 113 (03) :689-700
[2]   DEVELOPMENTAL-CHANGES IN SEMINIFEROUS TUBULE EXTRACELLULAR-MATRIX COMPONENTS OF THE MOUSE TESTIS - ALPHA-3(IV) COLLAGEN CHAIN EXPRESSED AT THE INITIATION OF SPERMATOGENESIS [J].
ENDERS, GC ;
KAHSAI, TZ ;
LIAN, G ;
FUNABIKI, K ;
KILLEN, PD ;
HUDSON, BG .
BIOLOGY OF REPRODUCTION, 1995, 53 (06) :1489-1499
[3]   GENETIC-HETEROGENEITY OF ALPORT SYNDROME [J].
FEINGOLD, J ;
BOIS, E ;
CHOMPRET, A ;
BROYER, M ;
GUBLER, MC ;
GRUNFELD, JP .
KIDNEY INTERNATIONAL, 1985, 27 (04) :672-677
[4]  
GATTONE BH, 1995, J AM SOC NEPHROL, V6, P694
[5]   THE CLINICAL SPECTRUM OF HEREDITARY NEPHRITIS [J].
GRUNFELD, JP .
KIDNEY INTERNATIONAL, 1985, 27 (01) :83-92
[6]   Glomerular basement membrane -: Identification of a novel disulfide-cross-linked network of α3, α4, and α5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome [J].
Gunwar, S ;
Ballester, F ;
Noelken, ME ;
Sado, Y ;
Ninomiya, Y ;
Hudson, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8767-8775
[7]  
HABIB R, 1982, KIDNEY INT S11, V21, P20
[8]  
HUDSON BG, 1993, J BIOL CHEM, V268, P26033
[9]  
JANSEN B, 1987, CAN J VET RES, V51, P387
[10]  
JANSEN B, 1986, J LAB CLIN MED, V107, P551